Nova Minerals (ASX:NVA) Soars on $43M US Critical Minerals Boost – Gold-Antimony Play to Watch
14 October 2025
2 mins read

Nova Minerals (ASX:NVA) Soars on $43M US Critical Minerals Boost – Gold-Antimony Play to Watch

  • Company: Nova Minerals (ASX:NVA; Nasdaq:NVA) is a dual-listed exploration/development company focused on gold and critical minerals. Its flagship Estelle Project (Alaska, 514 km²) hosts a JORC 9.9 million oz gold resource and large antimony (stibnite) deposits Novaminerals Globenewswire. Nova’s strategy is to advance Estelle toward production and develop a vertically‐integrated US antimony supply chain.
  • Recent News: In early Oct 2025 Nova announced key developments: a US$43.4 M grant from the US Department of War for antimony processing at Estelle Globenewswire, plus a land-use permit for a planned refinery at Port MacKenzie Globenewswire. On Oct 14 it was invited to brief US/Australian leaders ahead of the Oct 20 summit, triggering a stock rally Globenewswire Investing.
  • Stock Performance: NVA shares have jumped sharply. On 13 Oct the ASX share price closed ~$0.775, then ~0.90 on 14 Oct (a 7% daily gain) Intelligentinvestor. In US markets the ADR nearly doubled pre-open on Oct 14 Investing. Year-to-date the stock is up ~147%, and up ~389% over 12 months Stocktwits. (TradingView notes NVA has risen ~182% over the past month and ~400% year-over-year Tradingview.)
  • Fundamentals & Technicals: Nova remains pre-revenue with ongoing exploration spending – recent half-year net loss ~A$9M Tradingview and market cap ~$300–310 M Tradingview. Technically, most indicators are bullish: all moving averages (5,50,100,200-day) signal “Buy” and MACD is positive Investing. Investing.com labels NVA a “Strong Buy” based on these signals, though the 14-day RSI (~79) is in overbought territory Investing Investing.
  • Analysis & Commentary: Analysts note that Nova is now the first ASX-listed company to benefit from the US critical‑minerals push Smallcaps. SmallCaps and media point out this US backing could re-rate ASX juniors with US projects Smallcaps Oilprice. Nova’s CEO Gerteisen emphasizes that antimony is now a US strategic mineral, and Nova “is well-positioned to contribute to both U.S. and Australian critical minerals strategies” Oilprice. However, expert commentary (e.g. Simply Wall St) cautions that expectations are high: execution risk and further funding needs mean the stock could be “on the expensive side” after this run-up Simplywall Simplywall.
  • Outlook: In the short term, NVA may remain volatile. The Oct 20 Trump–Albanese summit and subsequent announcements could trigger further moves. In the long run, success hinges on executing Estelle’s development: if Nova can bring production online (targeting 2026/27 for military-grade antimony) it could validate bullish forecasts. (For context, a 2024 analyst report gave a US$25 ADR target Novaminerals, and mid-2023 targets implied A$1–$2+ by 2025–26 Novaminerals – vastly above current prices.) However, those high targets assume major advances and stable funding. Investors should weigh the large resource base and government support against the usual exploration risks (timeline delays, cost overruns, further dilution).

Sources: Nova Minerals official releases and filings Novaminerals Globenewswire; market news (Investing.com, OilPrice, Stocktwits, SmallCaps, SimplyWallSt) Investing Oilprice Stocktwits Smallcaps Simplywall; ASX trading data Intelligentinvestor; technical data (Investing.com) Investing Investing; analyst reports Novaminerals Novaminerals. Each cited source provides background and verification for the above analysis.

Stock Market Today

  • Tokyo Ohka Kogyo (TSE:4186) Up 23% in 3 Months as ROE Signals Growth Prospects
    January 11, 2026, 7:18 PM EST. Tokyo Ohka Kogyo shares have climbed about 23% over three months, prompting a closer look at fundamental drivers. The company reported a trailing ROE of around 15% for the year ending September 2025, meaning ¥0.15 profit for each ¥1 of equity. That compares with an industry average of 7.7%. Five-year net income has grown about 16%, above the industry's ~7% pace. If the company sustains such returns and reinvests profit wisely, earnings growth could outpace peers. Investors will want to see whether the P/E ratio already reflects this trajectory. In short, the uptrend appears to be supported by a solid return on equity and rising profits, but the stock will need to maintain earnings momentum to justify current pricing.
Cyngn (CYN) Stock Soars 500% on Nvidia Tie-Up – Bull Run or Bubble? Latest News, Forecasts & Risks
Previous Story

Cyngn (CYN) Stock Soars 500% on Nvidia Tie-Up – Bull Run or Bubble? Latest News, Forecasts & Risks

Strata Skin Sciences (SSKN) Stock Surges on Laser-Therapy Breakthrough – Buy, Hold or Sell?
Next Story

Strata Skin Sciences (SSKN) Stock Surges on Laser-Therapy Breakthrough – Buy, Hold or Sell?

Go toTop